All our
news

Discuss, meet & share

Press releases

Intrasense and Guerbet sign a licensing and integration agreement for artificial intelligence in oncology medical imaging

19 June 2023

Intrasense (FR0011179886 - ALINS), spécialiste des solutions logicielles d’imagerie médicale et concepteur de Myrian®, et Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announce the signature on June 19, 2023 of a license agreement to integrate and market Guerbet's artificial intelligence algorithms within Intrasense software platforms.

See the press release

Intrasense announces the co-option of a new director and the appointment of a new Chairman of its Board of Directors

25 May 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, annonces, the co-option of a new director to the Board, also appointed Chairman of the Board.

See the press release

2022 annual results: continued investments and renewed growth ambition

30 March 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and designer of Myrian® (the "Company"), today announced its consolidated (unaudited) 2022 IFRS financial results at Group level.

See the press release

Intrasense strengthens its porfolio with the signature of a contract with SATT Sud-Est

27 March 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, announces the signature of a technology transfer contract with SATT Sud-Est that will allow the company to acquire artificial intelligence algorithms dedicated to the detection of pulmonary nodules in radiology. These algorithms were developed by the Medical Imaging Unit of the Assistance Publique-Hôpitaux de Marseille (PIM/APHM), the Biological and Medical Magnetic Resonance Center (CRMBM) and the Mathematics Institute of Marseille (I2M).

See the press release

Intrasense and the ICM sign a partnership to optimize a new solution dedicated to oncology

6 February 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, has joined forces with the Montpellier Cancer Institute (ICM) through a partnership aimed at validating and then deploying its new platform dedicated to oncology in real-life situations, with the objective of using it in clinical routine.

See the press release

Our
conferences

WebinarsPodcasts

Our
articles

Do you want to receive our news in real time?

Subscribe